Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Melanoma”

928 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 928 results

Testing effectiveness (Phase 2)Ended earlyNCT01723813
What this trial is testing

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Who this might be right for
Metastatic Melanoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 6
Testing effectiveness (Phase 2)Study completedNCT00334776
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Southern California 6
Testing effectiveness (Phase 2)Study completedNCT00350597
What this trial is testing

GM-CSF as Adjuvant Therapy of Melanoma

Who this might be right for
Malignant Melanoma
Northern California Melanoma Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06070012
What this trial is testing

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Who this might be right for
Uveal Melanoma
Diwakar Davar 44
Testing effectiveness (Phase 2)Study completedNCT00121225
What this trial is testing

Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT04526899
What this trial is testing

Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVUnresectable Melanoma
BioNTech SE 184
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)UnknownNCT05135715
What this trial is testing

RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

Who this might be right for
Melanoma, Stage IIHER2-positiveAdvanced Melanoma
RemeGen Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT00162123
What this trial is testing

A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies

Who this might be right for
Melanoma
Bristol-Myers Squibb 248
Testing effectiveness (Phase 2)UnknownNCT01092585
What this trial is testing

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Who this might be right for
Melanoma
Genta Incorporated 27
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Testing effectiveness (Phase 2)Ended earlyNCT00072189
What this trial is testing

A Phase II Study of UCN-01 in Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 17
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableStudy completedNCT01886235
What this trial is testing

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)WithdrawnNCT04995094
What this trial is testing

Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma

Who this might be right for
Pathologic Stage III Cutaneous Melanoma AJCC v8
HiberCell, Inc.
Not applicableLooking for participantsNCT02828202
What this trial is testing

Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Who this might be right for
Malignant Melanoma
Assistance Publique - Hôpitaux de Paris 6,000
Testing effectiveness (Phase 2)Ended earlyNCT01264081
What this trial is testing

Lapatinib in Stage IV Melanoma With ERBB4 Mutations

Who this might be right for
Malignant Melanoma
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT04493203
What this trial is testing

Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma

Who this might be right for
Advanced MelanomaUnresectable Melanoma
Yana Najjar 31
Testing effectiveness (Phase 2)UnknownNCT03013101
What this trial is testing

Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Advanced MelanomaMetastatic Melanoma
Shanghai Junshi Bioscience Co., Ltd. 128
Testing effectiveness (Phase 2)Study completedNCT02493361
What this trial is testing

Trial of pIL-12/MK-3475 in Metastatic Melanoma

Who this might be right for
Melanoma
University of California, San Francisco 24
Load More Results